Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 286
Selected: 0
NCT IDTitle
NCT04285788Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
NCT00361842Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
NCT04899050Epidiolex in Typical Absence Seizures
NCT01461915Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
NCT00788892Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
NCT07282587Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
NCT04006925Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
NCT01696084Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
NCT02056782A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
NCT02565108A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT00711880A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
NCT03032016European VOD Registry
NCT02283281Anesthetic Premedication With a Cannabis Extract (Cannapremed)
NCT03878199Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
NCT02257684A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
NCT02224703GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
NCT05542407ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT05636111Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
NCT02596997Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
NCT00086281Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
NCT05392374Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
NCT02953548Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
NCT03555955A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
NCT04252586A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT00423813A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
NCT00674609A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
NCT05864846A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
NCT04732065ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
NCT03416530ONC201 in Pediatric H3 K27M Gliomas
NCT05244239Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
NCT04485104Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
NCT00628498Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
NCT03339401The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
NCT01610687A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT01217112GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
NCT05826756Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
NCT00713323A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.
NCT00514995Sodium Oxybate in the Treatment of Binge Eating Disorder
NCT01606202A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
NCT02420080A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
NCT03878927CPX-351+GO in Subjects 55 Years Old, or Older, With AML
NCT04657666Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
NCT02544750An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT03393611CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
NCT04425655Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
NCT00675948Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
NCT04794491An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy
NCT04984278Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis